Gea Oliveri Conti | Medicine and Dentistry | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Best Researcher Award

Gea Marzia Oliveri Conti, University of Catania

Gea Marzia Oliveri Conti
Affiliation University of Catania
Country Italy
Scopus ID 24332549000
Documents 186
Citations 9666
h-index 56
Subject Area Medicine and Dentistry
Event World Top Scientist Awards
ORCID 0000-0003-1857-8612

The Best Researcher Award recognizes significant academic contributions in the field of medical and environmental sciences. Gea Marzia Oliveri Conti has established a strong reputation through interdisciplinary research, combining environmental exposure analysis with public health outcomes. Her work reflects a consistent commitment to evidence-based scientific advancement. This recognition highlights both productivity and scholarly impact across international research communities [1].

Abstract

This article examines the academic profile and achievements of Gea Marzia Oliveri Conti in relation to the Best Researcher Award. Her work integrates environmental health risk assessment with clinical implications, offering valuable insights into population exposure risks. The study contextualizes her research outputs within global scientific standards. It also highlights citation metrics and research visibility across databases [2].

Keywords

Environmental health, epidemiology, exposure assessment, toxicology, and public health policy define the scope of this work. These keywords reflect the interdisciplinary nature of the research domain. They represent both applied and theoretical frameworks relevant to modern health sciences. The integration of these areas enhances research applicability in real-world scenarios.

Introduction

The Best Researcher Award acknowledges sustained excellence in scientific investigation and publication. Academic recognition at this level requires both productivity and measurable impact within a discipline. Oliveri Conti’s contributions align with international standards of research evaluation. Her work demonstrates methodological rigor and interdisciplinary integration [3].

Research Profile

The research profile includes over 186 indexed publications with significant citation counts. Her h-index reflects consistent scholarly influence across multiple studies. Research themes include environmental contaminants, health risk analysis, and epidemiological modeling. These contributions are widely recognized within medical and scientific communities.

Research Contributions

Her contributions focus on identifying environmental risk factors affecting human health. Studies often combine laboratory analysis with field-based observations. This integrated approach enhances the reliability of findings and policy relevance. The research supports preventive strategies in public health systems globally.

Publications

The author’s publications reflect a consistent focus on environmental toxicology and public health outcomes. Her work spans multiple peer-reviewed journals and collaborative studies across Europe. These publications contribute to advancing scientific understanding in exposure science. The consistency of research themes demonstrates long-term academic dedication.

Research Impact

Research impact is measured through citations, collaborations, and policy influence. Oliveri Conti’s work is frequently referenced in environmental health discussions. The high citation count indicates widespread academic engagement. Her findings contribute to both theoretical frameworks and applied health strategies [4].

Award Suitability

Eligibility for the award is based on measurable academic performance and research significance. The candidate’s profile demonstrates strong alignment with evaluation criteria. Her contributions reflect originality, consistency, and societal relevance. These qualities support recognition at international scientific award platforms.

Conclusion

The Best Researcher Award highlights distinguished academic achievements and global research contributions. Gea Marzia Oliveri Conti’s work exemplifies interdisciplinary excellence in health sciences. Her sustained productivity and impact justify scholarly recognition. This profile illustrates the importance of integrating environmental and medical research.

References

  1. Oliveri Conti, G. M., Ferrante, M., & Copat, C. (2020). Human biomonitoring and environmental exposure assessment: Implications for public health. Environmental Research, 188, 109123.
    https://doi.org/10.1016/j.envres.2020.109123
  2. Oliveri Conti, G. M., Grasso, A., & Fiore, M. (2019). Environmental pollution and human health risk assessment: Current perspectives. Science of the Total Environment, 650, 2190–2201.
    https://doi.org/10.1016/j.scitotenv.2018.09.123
  3. Oliveri Conti, G. M., Ledda, C., & Ferrante, M. (2018). Biomonitoring of environmental contaminants and related health effects. Journal of Hazardous Materials, 344, 1–10.
    https://doi.org/10.1016/j.jhazmat.2017.10.050
  4. Oliveri Conti, G. M., Copat, C., & Ferrante, M. (2021). Environmental epidemiology and exposure science in public health research. Environmental Pollution, 286, 117460.
    https://doi.org/10.1016/j.envpol.2021.117460
  5. Oliveri Conti, G. M., Fiore, M., & Ferrante, M. (2022). Environmental exposure assessment and preventive health strategies: A multidisciplinary approach. International Journal of Hygiene and Environmental Health, 242, 113950.
    https://doi.org/10.1016/j.ijheh.2022.113950

Odinakachukwu Ehie | Health Professions | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Best Researcher Award

Odinakachukwu Ehie – University of California

Odinakachukwu Ehie
Affiliation University of California
Country United States
Scopus ID 57219775629
Documents 241
Citations 248
h-index 6
Subject Area Health Professions
Event World Top Scientist Awards

The Best Researcher Award recognizes the scholarly contributions of Odinakachukwu Ehie, a researcher affiliated with the University of California. His academic work reflects sustained engagement in medical research, particularly within health professions education and perioperative care. The award is associated with the World Top Scientist Awards platform, which acknowledges impactful scientific contributions globally [1]. This recognition highlights both research productivity and interdisciplinary engagement in contemporary healthcare challenges.

Abstract

This article presents an overview of Odinakachukwu Ehie’s research achievements and academic recognition. It contextualizes his contributions within healthcare research and medical education innovation. The award reflects measurable scholarly impact and consistent publication output. Emphasis is placed on interdisciplinary approaches and global health perspectives [2].

Keywords

Medical Education, Perioperative Care, Health Disparities, Clinical Research, Academic Recognition

Introduction

Modern healthcare research increasingly emphasizes equity, innovation, and interdisciplinary integration. Researchers such as Ehie contribute to these evolving priorities through applied clinical studies and educational frameworks. His work spans multiple domains including anesthesia, communication barriers, and systemic disparities. These efforts align with broader institutional goals of improving patient outcomes [3].

Research Profile

Ehie’s research profile includes over 241 indexed publications and measurable citation impact. His work is cataloged in Scopus under Author ID 57219775629. The researcher’s contributions demonstrate engagement with both theoretical and applied medical sciences. His profile reflects ongoing collaboration across institutions and disciplines [1].

Research Contributions

Key contributions include work on pulse oximetry disparities and medical education frameworks. His research addresses structural inequities in healthcare delivery systems. Additional studies examine communication dynamics in pediatric anesthesia and curriculum development. These contributions reflect a commitment to improving healthcare quality and accessibility [4].

Publications

Ehie has authored and co-authored several peer-reviewed publications in reputable journals. These works include studies in JAMA, BJA Education, and BMC Medical Education. His publications address both clinical practice and educational innovation. The research demonstrates methodological rigor and relevance to contemporary healthcare challenges [5].

Research Impact

The impact of Ehie’s research is reflected in citation metrics and interdisciplinary application. His work contributes to policy discussions and clinical best practices. The research also informs educational strategies within medical training programs. Such influence underscores the relevance of his academic contributions [3].

Award Suitability

The Best Researcher Award recognizes consistent academic output and societal impact. Ehie’s contributions align with criteria emphasizing innovation and relevance. His interdisciplinary approach strengthens the applicability of research findings. This makes him a suitable candidate for global recognition platforms [2].

Conclusion

Odinakachukwu Ehie’s academic profile reflects sustained contributions to healthcare research. His work demonstrates both depth and breadth across multiple disciplines. Recognition through the Best Researcher Award highlights his scholarly impact. Continued research activity is expected to further advance the field.

References

  1. Lipnick, M. S., Ehie, O., Igaga, E. N., & Bicker, P. (2025). Pulse oximetry and skin pigmentation: New guidance from the FDA. JAMA, 333(16), 1393–1395.
    https://pubmed.ncbi.nlm.nih.gov/40042945/
  2. Ehie, O., Wondimagegn, D., Whitehead, C. R., & Lee, A. (2025). Critical theory in medical education. BJA Education, 25(7), 281–288.
    https://pubmed.ncbi.nlm.nih.gov/40575593/
  3. Ehie, O., Wood, A., Barreto Chang, O., Langnas, E., Vu, T., Lilaonitkul, M., & Gropper, M. (2026). Perioperative outcomes and health disparities: Transforming healthcare. Journal of the National Medical Association.
    https://doi.org/10.1016/j.jnma.2026.01.003
  4. Jain, R., Lewis, L., Brooks, K., Shaahinfar, A., Stine, S., Marbin, J., & Ehie, O. (2026). Assessing the effectiveness of an antiracism clinical skills curriculum for medical students: A single institution mixed methods study. BMC Medical Education.
    https://doi.org/10.1186/s12909-026-08854-z
  5. Branche, K., Gallardo, P., Carreon, Y., & Ehie, O. (2026). Enhancing communication in pediatric anesthesia: The impact of language barriers on caregiver and provider interaction. Pediatric Anesthesia, 36(3), 271–280.
    https://doi.org/10.1002/pan.70102

Klaus Schmitz-Abe | Medicine and Dentistry | Best Researcher Award | 4538

Published on | Editorial Board by World Top Scientists

Best Researcher Award

Klaus Schmitz-Abe
Affiliation University of Miami
Country United States
Scopus ID 55566516000
Documents 2133
Citations 2284
h-index 26
Subject Area Medicine and Dentistry
Event World Top Scientist Awards
ORCID 0000-0002-7242-8861

Klaus Schmitz-Abe – University of Miami

Klaus Schmitz-Abe is a biomedical researcher affiliated with the University of Miami and recognized for his contributions to genomic medicine, rare disease research, computational biology, and clinical genetics. His academic activities integrate advanced sequencing technologies, bioinformatics methodologies, and translational research approaches that support the identification and interpretation of disease-causing genetic variants. Through collaborations with leading healthcare and research institutions, he has contributed to projects focused on improving diagnostic precision and expanding knowledge of inherited disorders. His research profile reflects a multidisciplinary approach that bridges computational science with clinical medicine, supporting innovation in precision healthcare and evidence-based patient management.[1]

Abstract

This article presents an academic overview of Klaus Schmitz-Abe in relation to the Best Researcher Award. His research activities encompass genomic medicine, human genetics, rare disease diagnostics, computational biology, and translational healthcare. Through collaborative investigations and publication of peer-reviewed studies, he has contributed to improving the understanding of genetic disorders and advancing modern diagnostic methodologies. His work demonstrates the integration of bioinformatics, sequencing technologies, and clinical interpretation frameworks that support precision medicine initiatives. The combination of scientific productivity, interdisciplinary collaboration, and translational relevance highlights a research profile suitable for international academic recognition.[2]

Keywords

Genomic Medicine, Human Genetics, Rare Diseases, Bioinformatics, Clinical Genomics, Precision Medicine, Immunology, Translational Research.

Introduction

The growing importance of genomic technologies has transformed the way researchers investigate inherited diseases and complex medical conditions. Scientists working in this field contribute significantly to improving diagnostic accuracy and expanding the understanding of disease mechanisms. Klaus Schmitz-Abe has participated in research efforts that combine computational methods with clinical investigation, creating opportunities for more efficient genetic diagnosis and personalized healthcare solutions. His scholarly work reflects the evolving role of genomics in contemporary medicine and biomedical research.[3]

Research Profile

Klaus Schmitz-Abe has held research and academic appointments associated with the University of Miami, Harvard Medical School, Boston Children’s Hospital, and several collaborative genomic research initiatives. His expertise includes next-generation sequencing, variant interpretation, copy number variation analysis, phenotype-driven diagnostics, and bioinformatics. These areas of specialization have enabled him to participate in multidisciplinary projects involving rare diseases, immune disorders, and developmental conditions. His professional activities demonstrate continuous engagement with clinical and translational research programs focused on improving patient outcomes through genomic science.[1]

Research Contributions

The scientific contributions of Klaus Schmitz-Abe include studies addressing genetic disorders, immunological diseases, autism spectrum conditions, and genomic diagnostic methodologies. His work frequently focuses on identifying clinically relevant genetic variants and improving analytical frameworks used in medical genetics. Several publications highlight the application of computational approaches and integrated genomic analyses that increase diagnostic yield and support precision medicine. These contributions have enhanced scientific understanding while also providing practical value for clinical decision-making and healthcare innovation.[4]

Publications

  • Unique Signatures of Highly Constrained Genes Across Publicly Available Genomic Databases (2025).
  • RELMβ Sets the Threshold for Microbiome-Dependent Oral Tolerance (2025).
  • DOCK8 Deficiency Due to a Deep Intronic Variant in Hyper-IgE Syndrome (2024).
  • Homozygous Deletions Implicate Non-Coding Epigenetic Marks in Autism Spectrum Disorder (2020).
  • Unique Bioinformatic Approach and Comprehensive Reanalysis Improve Diagnostic Yield of Clinical Exomes (2019).

These publications illustrate sustained engagement with genomics, immunology, and rare disease research. The studies collectively demonstrate an emphasis on clinically relevant discoveries, methodological innovation, and translational applications. Research findings reported in these works contribute to the advancement of genetic diagnostics and support broader scientific efforts aimed at understanding disease biology and improving patient care.[5]

Research Impact

Research impact can be assessed through scholarly productivity, citation influence, collaborative participation, and translational significance. The academic record associated with Klaus Schmitz-Abe demonstrates continued involvement in projects that address important challenges in genomic medicine and clinical genetics. His contributions have supported the development of diagnostic strategies and generated findings relevant to healthcare professionals, researchers, and patients. The combination of scientific output and practical relevance strengthens the overall significance of his research portfolio.[2]

Award Suitability

The Best Researcher Award recognizes excellence in scientific achievement, innovation, collaboration, and measurable academic contribution. Klaus Schmitz-Abe’s work aligns with these criteria through his multidisciplinary research activities and sustained publication record. His involvement in genomic medicine, rare disease investigation, and computational biology reflects a commitment to advancing scientific knowledge while supporting practical clinical applications. Such achievements provide a strong foundation for recognition within an international academic award framework.[3]

Conclusion

Klaus Schmitz-Abe has developed a research profile characterized by interdisciplinary collaboration, scientific productivity, and contributions to genomic medicine. His work supports advances in rare disease diagnosis, precision medicine, and computational genetics while maintaining strong relevance to modern healthcare challenges. Through peer-reviewed publications, collaborative research programs, and translational investigations, he has contributed to the ongoing evolution of biomedical science. These accomplishments collectively support his recognition within the Best Researcher Award category.[4]

References

  1. ORCID. Klaus E. Schmitz-Abe Profile.
    https://orcid.org/0000-0002-7242-8861
  2. Unique Signatures of Highly Constrained Genes Across Publicly Available Genomic Databases.
    https://doi.org/10.1016/j.gim.2025.101413
  3. RELMβ Sets the Threshold for Microbiome-Dependent Oral Tolerance.
    https://doi.org/10.1038/s41586-024-08440-7
  4. DOCK8 Deficiency Due to a Deep Intronic Variant in Two Kindreds with Hyper-IgE Syndrome.
    https://doi.org/10.1016/j.clim.2024.110384
  5. Unique Bioinformatic Approach and Comprehensive Reanalysis Improve Diagnostic Yield of Clinical Exomes.
    https://doi.org/10.1038/s41431-019-0401-x

Funmilola Adewinle | Medicine and Dentistry Obafemi | Research Excellence Award

Published on | Editorial Board by World Top Scientists

Dr. Funmilola Adewinle | Medicine and Dentistry Obafemi | Research Excellence Award

Consultant | Awolowo University Teaching Hospital | Nigeria

Dr. Funmilola Eunice Adewinle is a Consultant at the Obafemi Awolowo University Teaching Hospital, Ile-Ife, with recognized expertise in oral medicine, orofacial pain, and headache disorders. She holds a Bachelor’s degree in Dentistry and Dental Surgery, a Master’s degree in Public Health, and a Fellowship in Oral Medicine, and is completing advanced doctoral training in orofacial pain. Her professional practice combines specialist clinical care with active research engagement, contributing to improved understanding and management of complex pain conditions. She is involved in multiple ongoing and completed research projects addressing neuropathic orofacial pain, burning mouth syndrome, migraine-related disorders, dental anxiety, and pain biomarkers, with publications in reputable international journals indexed by Elsevier and SAGE. Her work has provided novel population-specific evidence on vitamin D status and neuropathic orofacial pain, helping to address gaps in global literature and informing evidence-based clinical decision-making. Dr. Adewinle actively collaborates with international research groups through the World Workshop on Oral Medicine WONDER Project and the International Headache Society initiatives. She is a professional member of the International Headache Society and the Nigerian Association of Oral Maxillofacial Pathology and Medicine, reflecting her commitment to continuous professional development and global scientific engagement. Her career demonstrates a strong blend of clinical excellence, research innovation, and international collaboration, positioning her as a deserving candidate for the Research Excellence Award.

Profiles: ORCID

Featured Publications

1. Adewinle, F. E., Owotade, F. J., Komolafe, M. A., Adedeji, T. A., Oyetola, E. O., Adekanmbi, O. G., & Olukoyejo, O. E. (2025). Neuropathic orofacial pain is associated with low serum vitamin D: A case control study. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology.

2. Mascarella, D., Zhuang, Z. A., Gliga, O., De Santis, F., Rosignoli, C., Daputke, A., Njohjam, M. N., Mazzotta, E., Adewinle, F. E., Caronna, E., et al. (2025). Migraine in monogenic disorders: Shedding light on new therapeutic targets. Cephalalgia.

Dr. Funmilola Eunice Adewinle’s work advances understanding of orofacial pain and headache disorders, providing evidence-based insights that improve patient care and inform clinical guidelines. Her research addresses critical gaps in global health knowledge, fostering innovation in diagnosis, management, and therapeutic strategies for pain-related conditions.

Feyera Gemeda | Infectious Diseases | Outstanding Scientist Award

Published on | Editorial Board by World Top Scientists

Assoc. Prof. Dr. Feyera Gemeda | Infectious Diseases | Outstanding Scientist Award

Associate Professor | Dima Jimma university | Ethiopia

Assoc. Prof. Dr. Feyera Gemeda Dima is a distinguished researcher and academic with extensive experience in Infectious Diseases, Medical Mycology, and Medicine. He has demonstrated excellence in teaching, research, and mentorship at both national and international levels, fostering the development of students and early-career researchers. His work emphasizes innovation in scientific research, editorial contributions, and leadership in grant assessment and curriculum development. He has contributed significantly to global collaborations and serves as a Chief Scientist and Global Assessor, reflecting his commitment to advancing scientific knowledge. His research focuses on improving understanding and management of infectious diseases, with the potential to influence public health strategies. Prof. Gemeda’s dedication to integrating innovative approaches and interdisciplinary perspectives underscores his capacity for impactful contributions in the field.

Profile:  Google Scholar

Featured Publications

1. T. Gizaw and F. G. Dima, “Assessment of problems and constraints associated with artificial insemination service in the two selected districts of Arsi zone,” Journal of Harmonized Research in Medical and Health Sciences, vol. 3, no. 1, pp. 14–37, 2016.

2. A. Edao, F. G. Dima, and F. B. Deressa, “Prevalence of bovine cysticercosis and status of human taeniasis in and around Asella town, Tiyoworeda, south east Ethiopia,” Glob J Med Res, vol. 16, pp. 18–26, 2016.

3. F. Gemeda, “Prevalence of bovine Trypanosomosis in and around Nekemte areas, east Wollega zone, Ethiopia,” Open Access Library Journal, vol. 2, no. 05, p. 1, 2015.

4. D. T. Legesse and F. Gemeda, “Comparison of two parasitological tests and post mortem examination to detect prevalence of bovine fasciolosis at Ambo Town Municipal Abattoir, West Shewa Zone, Ethiopia,” Open Access Library Journal, vol. 2, no. 8, pp. 1–5, 2015.

5. F. G. Dima and T. Fikedu, “Review on infectious bovine keratoconjunctivitis,” J Bacteriol Infect Dis, vol. 4, no. 4, pp. 1–6, 2021.

Dr. Gemeda’s work advances the understanding and control of infectious diseases, providing evidence-driven insights that strengthen public health systems and guide global disease management strategies.

Javad Amini Mahabadi | Medicine and Dentistry | Editorial Board Member

Published on | Editorial Board by World Top Scientists

Dr. Javad Amini Mahabadi | Medicine and Dentistry | Editorial Board Member

Javad Amini Mahabadi  | Kashan University of Medical Sciences | Iran

Dr. Javad Amini Mahabadi, a reproductive biologist and faculty member at Kashan University of Medical Sciences, is recognized for his expertise in reproductive biology, IVF, and stem-cell–based approaches to fertility science. He holds advanced degrees culminating in a Ph.D. in Reproductive Biology, with specialized training in assisted reproductive technologies and cellular therapeutics. His professional experience includes leading laboratory initiatives in gamete and embryo research, contributing to multidisciplinary reproductive health projects, mentoring emerging scientists, and supporting institutional development through academic and committee service. Dr. Amini Mahabadi’s research focuses on reproductive physiology, embryo development, and innovative stem-cell applications, reflected in a substantial body of peer-reviewed publications and a strong citation record demonstrating sustained scientific impact. His contributions extend to methodological advancements and collaborative work aimed at improving clinical and translational outcomes in reproductive medicine. He has received institutional and professional recognitions for research excellence, serves in editorial and peer-review roles for respected journals, and maintains active membership in scientific societies that promote reproductive health and biomedical innovation.

Profiles: Google Scholar

Featured Publications

1. Mohammadi, F., Nikzad, H., Taherian, A., Amini Mahabadi, J., & Salehi, M. (2013). Effects of herbal medicine on male infertility. Anatomical Sciences Journal, 10(4), 3–16.

2. Aghaei, S., Nikzad, H., Taghizadeh, M., Tameh, A. A., Taherian, A., & Moravveji, A. (2014). Protective effect of pumpkin seed extract on sperm characteristics, biochemical parameters and epididymal histology in adult male rats treated with cyclophosphamide. Andrologia, 46(8), 927–935.

3. Abazari, M. F., Soleimanifar, F., Aleagha, M. N., Torabinejad, S., Nasiri, N., … (2018). PCL/PVA nanofibrous scaffold improve insulin-producing cells generation from human induced pluripotent stem cells. Gene, 671, 50–57.

4. Abazari, M. F., Soleimanifar, F., Amini Faskhodi, M., Mansour, R. N., … (2020). Improved osteogenic differentiation of human induced pluripotent stem cells cultured on polyvinylidene fluoride/collagen/platelet-rich plasma composite nanofibers. Journal of Cellular Physiology, 235(2), 1155–1164.

5. Tahmasebi, A. T., Enderami, S. E., Saburi, E., Islami, M., … (2019). MicroRNA incorporated electrospun nanofibers improve osteogenic differentiation of human induced pluripotent stem cells. Journal of Biomedical Materials Research, 108(2), 377–386.

Dr. Javad Amini Mahabadi’s work advances reproductive biology and stem-cell–based innovation, contributing to improved fertility outcomes and translational biomedical solutions. His research supports scientific progress, strengthens clinical practices, and fosters technologies that enhance public health and future therapeutic development.

Sedighe Sadat Tabatabaei Far | Health Professions | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Ms. Sedighe Sadat Tabatabaei Far | Health Professions | Best Researcher Award

PhD Candidate at Shiraz University of Medical Sciences, Iran

Sedighe Sadat Tabatabaei Far is a dedicated PhD candidate in Healthcare Services Management at the School of Health Management and Information Sciences, Shiraz University of Medical Sciences, Iran. Her research focuses on critical areas such as healthcare workforce management, disaster preparedness, and cost-effectiveness in cancer treatment. She has contributed to peer-reviewed publications on topics like healthcare worker retention during epidemics, nurses’ disaster preparedness, and chemotherapy cost-effectiveness, demonstrating a well-rounded understanding of both operational and strategic aspects of health systems. As an emerging scholar, she shows strong potential through her interdisciplinary approach, blending public health, management, and economic analysis. While her citation metrics are still developing, her work addresses timely and impactful issues relevant to both national and global healthcare challenges. With continued scholarly engagement and expanded collaboration, she is well-positioned to make significant contributions to the field of health services research.

🔹Professional Profile 

Google Scholar
Scopus Profile
ORCID Profile

🏆Strengths for the Award

1. Published in Peer‑Reviewed Journals on Timely Health Topics
Dr. Tabatabaei Far has authored several peer‑reviewed articles addressing critical issues in healthcare management, including a scoping review on retention of healthcare workers during epidemic disasters (2021), an analysis of nurses’ knowledge and performance on disaster management (2020), and a study on the cost‑effectiveness of chemotherapy regimens for stage IV colorectal cancer (2023). Her research is both relevant to public health preparedness and clinical decision‑making.

2. Interdisciplinary Expertise in Health System Resilience
Her work engages both operational (cost‑effectiveness analysis) and human resources dimensions (staff retention, disaster readiness), indicating a broad methodological skill set and the capacity to blend quantitative health economics with behavioral management insights.

3. Emerging Scholarly Profile
Though early in her academic career, she has already contributed multiple publications and demonstrated engagement with national and international health challenges pertinent to Iranian healthcare and potentially beyond.

🎓 Education

Sedighe Sadat Tabatabaei Far has pursued her higher education with a clear focus on health system improvement and management. She is currently enrolled as a PhD candidate in Healthcare Services Management at the School of Health Management and Information Sciences, Shiraz University of Medical Sciences in Iran. Prior to her doctoral studies, she completed her Master’s degree in the same field at the same university, where she built a strong foundation in health policy, system evaluation, and management strategies. Her academic coursework has included areas such as healthcare economics, strategic planning, disaster management, and hospital operations. Her educational background reflects a consistent commitment to evidence-based management practices in healthcare. Throughout her academic career, she has demonstrated intellectual curiosity and a strong capacity for research, often collaborating with interdisciplinary teams to address emerging challenges in healthcare delivery and administration. Her educational achievements have laid the groundwork for impactful and policy-relevant research.

🏥 Experience

Sedighe Sadat Tabatabaei Far brings diverse experience in both academic research and collaborative healthcare projects. As a PhD candidate, she has participated in several national and institutional research initiatives, primarily under the Student Research Committee at Shiraz University of Medical Sciences. Her practical experience includes working with hospital and university teams to assess healthcare delivery systems, evaluate workforce performance, and develop disaster preparedness frameworks. She has also contributed to projects focusing on the cost-effectiveness of treatment regimens, specifically in oncology. Sedighe has served in various roles such as research assistant, data analyst, and project coordinator, allowing her to engage with data collection, literature review, statistical analysis, and scientific writing. Her exposure to both theoretical and applied dimensions of healthcare management enhances her ability to propose actionable recommendations for policy and practice. Through these experiences, she has honed her analytical, communication, and project management skills, which are essential for success in health services research.

🏆 Awards and Honors

Sedighe Sadat Tabatabaei Far has received recognition for her growing contributions to healthcare research and academic excellence. While early in her academic career, she has already been acknowledged through institutional honors and involvement in competitive research programs. As a member of the Student Research Committee, she has been entrusted with responsibilities that reflect her dedication and capability in leading health-related studies. Her research has been selected for presentation and publication in peer-reviewed outlets, demonstrating academic merit. In addition, she has been recognized for her work on timely issues such as workforce retention during pandemics and cost-effective treatment strategies. Although she has not yet accumulated major international awards, her trajectory suggests a strong potential for future honors. Her continued engagement with meaningful topics and her consistent output of quality research position her as a competitive candidate for both national and international recognitions in healthcare management and research excellence.

🔬 Research Focus on Health Profession

Sedighe Sadat Tabatabaei Far’s research is centered on enhancing the efficiency, resilience, and responsiveness of healthcare systems. Her primary focus includes healthcare workforce management, especially retention strategies during health crises, as well as disaster preparedness among frontline workers. Another critical area of her work is health economics—evaluating the cost-effectiveness of clinical treatments, with a recent emphasis on chemotherapy for colorectal cancer. She employs both qualitative and quantitative methodologies, including scoping reviews, survey research, and economic evaluation frameworks. Her interdisciplinary approach allows her to address operational, strategic, and policy-level questions in healthcare. Sedighe’s research is driven by the goal of improving service delivery in hospitals and public health systems, particularly within resource-constrained settings. She also maintains an interest in how healthcare systems respond to pandemics and disasters, aiming to generate evidence that informs practical planning and policy. Her ongoing work seeks to bridge the gap between academic research and real-world health system needs.

📚Publications Top Notes

  • Title: Nurses’ knowledge, attitude, and performance about disaster management: A case of Iran
    Authors: SST Far, MA Marzaleh, N Shokrpour, R Ravangard
    Year: 2020
    Citations: 19

  • Title: A scoping review on interventions for retention of healthcare workers in epidemic disasters
    Authors: SST Far, T Kushki, M Jamshidi, S Delavari
    Year: 2021
    Citations: 4

  • Title: Cost-effectiveness of FOLFOX6+ bevacizumab versus FOLFOX6+ cetuximab in stage IV colorectal cancer patients in Shiraz, Iran
    Authors: A Jafari, SS Tabatabaei Far, M Dehghani, R Ravangard
    Year: 2023
    Citations: 2

  • Title: Resilience model of public health sector during unknown pandemics: a grounded theory approach for COVID-19 in Iran
    Authors: O Sadeghkhani, P Mehdi Alamdarloo, MA Mahmoodi Mehr, SS Tabatabaei Far, et al.
    Year: 2025
    Citations: 1

  • Title: Comparison of quality of care and welfare services for middle-aged and older disabled individuals in Iran and Lebanon using ServQual model
    Authors: SST Far, NP Jahromi, SM Al-Zoubi, A Abyad, A Asadollahi
    Year: 2025
    Citations: 1

  • Title: Studying The Mental Health Status Of Nurses In The Era Of Covid-19 (A Rapid Review Study In Iran)
    Authors: M Zare, Z Kavosi, SS Tabatabaei Far
    Year: 2024
    Citations: 1

  • Title: A Review of the Procrastination Phenomenon among Hospital Employees in Iran
    Authors: H Dastan, SS Tabatabaei Far, M Ghanbari-Jahromi, Z Kavosi
    Year: 2025

🎯 Conclusion

Sedighe Sadat Tabatabaei Far exemplifies the qualities of a committed and impactful early-career researcher in healthcare services management. Through her focused academic background, growing body of peer-reviewed publications, and engagement with pressing public health issues such as disaster preparedness, workforce retention, and cost-effectiveness analysis, she demonstrates a keen understanding of both operational and strategic healthcare challenges. Her interdisciplinary approach—combining health economics, management, and policy—adds meaningful value to the field. Though still building her citation impact and international visibility, her steady progress and contributions to collaborative research efforts position her as a rising voice in the global health research community. With continued academic engagement, mentorship, and broader collaboration, she holds strong potential to evolve into a thought leader in healthcare systems strengthening. Sedighe’s trajectory reflects both academic dedication and a deep-seated drive to improve healthcare delivery, making her a compelling candidate for recognition such as the Best Researcher Award.

Laura Garriga-Grimau | Medicine and Dentistry | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Dr. Laura Garriga-Grimau | Medicine and Dentistry | Best Researcher Award

Physician at Hospital Universitari Vall d’Hebron, Spain

Dr. Laura Garriga-Grimau is a dedicated pediatric pulmonologist based at Vall d’Hebron University Hospital in Barcelona, Spain. She specializes in bronchiectasis, cystic fibrosis, and other chronic pediatric lung conditions. Her work bridges clinical practice, academic research, and teaching. She is actively involved in multiple international research collaborations, including the European Respiratory Society (ERS) and the Child-BEAR-Net Registry. A strong advocate for improving respiratory care in children, Dr. Garriga-Grimau has authored numerous peer-reviewed publications and contributed to global studies shaping pediatric lung health guidelines. Her academic and clinical background is enriched by international clinical training in Australia and active teaching roles at the Autonomous University of Barcelona. Known for her collaborative leadership and deep scientific insight, she continues to contribute to innovation in pediatric respiratory medicine while mentoring future healthcare professionals. Her work is both evidence-driven and patient-centered, earning her a growing reputation in European and global pediatric research communities.

🔹 Professional Profile 

Scopus Profile
ORCID Profile 

🏆Strengths for the Award

Dr. Laura Garriga-Grimau has demonstrated a strong commitment to advancing pediatric respiratory medicine through a blend of clinical excellence, academic research, and international collaboration. Her specialization in bronchiectasis and cystic fibrosis has positioned her as a key contributor in areas that are often underrepresented in pediatric research. She currently holds leadership roles in prominent research initiatives, such as Chair of the ERS Task Force on Transitioning Adolescents with Bronchiectasis, and Deputy Co-Chair of the Child-BEAR-Net Registry, reflecting the recognition she commands within global respiratory research communities. These roles not only highlight her scientific insight but also her ability to coordinate multinational teams and influence clinical policy development.

Her publication record is both prolific and impactful, including research in The Lancet Respiratory Medicine, New England Journal of Medicine, and other peer-reviewed international journals. Dr. Garriga-Grimau has contributed to high-quality, multi-center studies and registries that address real-world challenges in diagnosis, treatment, and care models for pediatric lung diseases. Notably, her involvement in the SHIP-CT trial and the Spanish Pediatric Bronchiectasis Registry demonstrates her ability to participate in and lead complex clinical research initiatives with both academic and translational value. Her research outputs are data-driven, well-cited, and directly relevant to improving health outcomes in children globally.

In addition to her research achievements, Dr. Garriga-Grimau has actively bridged the gap between academia and clinical practice. She contributes as a faculty member in the Pediatric Pulmonology Master’s program at the Autonomous University of Barcelona and has been involved in mentoring and training future clinicians and researchers. Her international clinical exposure, including a bronchiectasis fellowship in Australia, enhances the global relevance and cultural sensitivity of her work. This combination of academic productivity, clinical innovation, and leadership in international research networks makes her a well-rounded and highly deserving candidate for the Best Researcher Award.

🎓Education

Dr. Laura Garriga-Grimau completed her medical education and pediatric residency through the Spanish MIR system at the University of Barcelona, one of Spain’s leading academic medical centers. Following her pediatric training, she pursued specialized academic advancement through a Master’s degree in Pediatric Pulmonology from the Autonomous University of Barcelona (UAB), where she later became a faculty member. Her passion for research and respiratory medicine led her to complete a PhD focused on cystic fibrosis at Vall d’Hebron University Hospital, contributing significant findings to the field. In addition to her formal education, Dr. Garriga-Grimau enriched her academic and clinical knowledge with a training fellowship in bronchiectasis at the Queensland Children’s Hospital in Australia. Her continuous pursuit of learning, from clinical practice to translational research, has equipped her with a strong foundation in evidence-based medicine and multidisciplinary collaboration, shaping her into a leader in pediatric respiratory care both in Spain and internationally.

💼 Experience

Dr. Laura Garriga-Grimau has built an extensive and dynamic professional career in pediatric pulmonology, anchored at Vall d’Hebron University Hospital. She serves as a consultant in the Pediatric Pulmonology Department, where she treats complex respiratory conditions, including cystic fibrosis and bronchiectasis. Her clinical experience is complemented by her academic involvement as a lecturer in the Pediatric Pulmonology Master’s program at the Autonomous University of Barcelona. She completed international clinical training in Australia, focusing on bronchiectasis, and collaborates with research networks such as the ERS, ERN-Lung, and Child-BEAR-Net. Her career integrates hands-on patient care with data-driven research, highlighting her ability to translate science into practice. In leadership roles such as Chair of the ERS Task Force on adolescent bronchiectasis transition and Deputy Co-Chair of Child-BEAR-Net, she coordinates multinational teams and projects. Her balanced experience across clinical, research, and educational domains establishes her as a well-rounded and forward-thinking physician-scientist.

🏆 Awards and Honors

While specific individual awards are not listed in her profile, Dr. Laura Garriga-Grimau’s numerous prestigious roles and peer-reviewed publications serve as strong indicators of her academic and professional recognition. She has earned notable leadership positions in internationally recognized research bodies such as the European Respiratory Society (ERS) and the Child-BEAR-Net network, which are typically awarded based on merit, contribution, and peer endorsement. She is a key author and collaborator in top-tier journals including The Lancet Respiratory Medicine and The New England Journal of Medicine—an honor in itself that reflects a high level of expertise and scientific impact. Her inclusion in global studies and research registries, as well as her involvement in shaping clinical guidelines, affirms her reputation in the field of pediatric pulmonology. Furthermore, her appointment as faculty at a major academic institution and her PhD achievements represent high academic recognition within both national and international medical communities.

🔬Research Focus on Medicine and Dentistry

Dr. Garriga-Grimau’s research centers on pediatric bronchiectasis, cystic fibrosis, and related respiratory disorders, with an emphasis on improving diagnostics, treatment protocols, and health equity in chronic pediatric lung care. She is actively involved in several major international studies and registries, including the Child-BEAR-Net Registry and SHIP-CT trial. Her research evaluates multicountry clinical variations, healthcare transitions from adolescence to adulthood, and therapy optimization for children with chronic respiratory disease. She collaborates on translational studies that influence clinical guidelines and promote standardized care across different healthcare systems. Her work particularly emphasizes underserved populations, including Indigenous communities, reflecting her commitment to inclusive, global health research. By integrating clinical experience with robust epidemiological and translational approaches, Dr. Garriga-Grimau’s research not only advances scientific understanding but also directly enhances patient outcomes. She contributes to major publications and plays key roles in shaping pediatric pulmonology’s research priorities at the European and global level.

📚 Publications Top Notes

  • First results from the international paediatric bronchiectasis registry (Child‑BEAR‑Net Registry) describing multicountry variations in childhood bronchiectasis and its management: a multicentre, cross‑sectional study

    • Authors: Laura Garriga‑Grimau; Ahmad Kantar; Keith Grimwood; Charl Verwey; Refiloe Masekela; Diane Gray; Ameena Goga; Bulent Karadag; Ela Erdem Eralp; Yasemin Gokdemir; et al.

    • Year: 2025

    • Citations: 1 (as per Scopus/ResearchGate)

  • Guiding practice principles for clinicians who work with Indigenous people

    • Authors: André Schultz; Anne B. Chang; Donna M. Mason; Julie M. Marchant; Lesley A. Versteegh; Maree Toombs; Laura Garriga‑Grimau; CRE Extended Group

    • Year: 2025

  • Bronchiectasis in pediatrics

    • Authors: Laura Garriga‑Grimau; Eva Polverino; Antonio Moreno‑Galdó

    • Year: 2025

  • Implementation of the Spanish Paediatric Bronchiectasis Registry (Child‑BEAR‑es Registry)

    • Authors: Laura Garriga‑Grimau; Verónica Sanz‑Santiago; Antonio Moreno‑Galdó

    • Year: 2024

  • Improving the Diagnosis and Treatment of Paediatric Bronchiectasis Through Research and Translation

    • Authors: Anne B. Chang; Shyamali C. Dharmage; Julie M. Marchant; Gabrielle B. McCallum; Peter S. Morris; Andre Schultz; Maree Toombs; Danielle F. Wurzel; Stephanie T. Yerkovich; Keith Grimwood; Laura Garriga‑Grimau; CRE extended group

    • Year: 2024

  • Asma (book chapter)

    • Author: Laura Garriga‑Grimau

    • Year: 2022

  • Pneumònia per Streptococcus pyogenes a l’edat pediàtrica

    • Author: Laura Garriga‑Grimau

    • Year: 2022

  • The effect of inhaled hypertonic saline on lung structure in children aged 3–6 years with cystic fibrosis (SHIP‑CT)

    • Authors: Harm A.W.M. Tiddens; Yuxin Chen; Eleni‑Rosalina Andrinopoulou; et al., including Laura Garriga‑Grimau

    • Year: 2022

  • Triple Therapy for Cystic Fibrosis Phe508del‑Gating and ‑Residual Function Genotypes

    • Authors: Peter J. Barry; Marcus A. Mall; Antonio Álvarez; et al., including Laura Garriga‑Grimau

    • Year: 2021

  • How abnormal is the normal? Clinical characteristics of CF patients with normal FEV₁

    • Authors: Malena Cohen‑Cymberknoh; Elad Ben Meir; Silvia Gartner; et al., including Laura Garriga‑Grimau

    • Year: 2021

  • Earlier clinical case reports (2012–2015)

    • Authors: Laura Garriga‑Grimau et al.

    • Years: 2012–2015

📌 Conclusion

Dr. Laura Garriga-Grimau exemplifies the rare combination of clinical expertise, academic leadership, and collaborative spirit essential for advancing global pediatric pulmonology. Her commitment to research excellence, her leadership in multinational registries and task forces, and her drive to improve outcomes for children with chronic respiratory diseases mark her as an innovator in the field. Whether through her patient care, her mentorship of future specialists, or her groundbreaking studies in bronchiectasis and cystic fibrosis, Dr. Garriga-Grimau continues to push the boundaries of pediatric respiratory medicine. Her contributions resonate not only within academic journals but also in real-world clinical settings across borders. As she builds on her already distinguished career, she remains a key force in shaping the future of respiratory healthcare for children worldwide. Dr. Garriga-Grimau is undoubtedly a deserving candidate for any accolade recognizing research excellence, innovation, and global impact in medicine.

Leonardo Mayorga | Immunology and Microbiology | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Dr. Leonardo Mayorga | Immunology and Microbiology | Best Researcher Award 

Medical microbiologist at Universidad de Guadalajara Centro Universitario de Ciencias de la Salud: Guadalajara, Jalisco, Mexico

Leonardo Mayorga is a highly accomplished biologist specializing in medical microbiology and infectious diseases, with a particular focus on mycology and mycobacteriology. He holds a degree from the University of Guadalajara and advanced postgraduate training in his field. Leonardo combines clinical practice with academic excellence, serving as a professor in prestigious institutions such as the University of Milan and the Hospital General de Hermosillo. He is the founder of the dermatological mycology diploma at the Colegio Ibero Latinoamericano de Dermatología (CILAD), showcasing his commitment to advancing education in this niche. His leadership extends internationally as the Director of International Relations for the Worldwide Dermatology Collaboration Society, and nationally as the Secretary of the Mexican Association of Medical Mycology. Additionally, he contributes to scientific scholarship as a member of the editorial board for the Worldwide Dermatology Journal. Leonardo’s career reflects a blend of research, teaching, and professional service, marking him as a key figure in his specialized field of medical mycology.

Professional Profile 

ORCID Profile

Education

Leonardo Mayorga holds a degree in Biology from the University of Guadalajara, where he laid the foundation for his scientific career. He further specialized through postgraduate studies in Medical Microbiology and Infectious Diseases at the same university, deepening his expertise in the diagnosis and treatment of infectious pathogens. His academic training is complemented by focused clinical specialization in mycology and mycobacteriology, fields that require detailed knowledge of fungal and mycobacterial infections, respectively. This comprehensive education equips him to address complex infectious diseases from both a laboratory and clinical perspective. His continuous commitment to education is reflected in his roles as an educator and program founder, underlining a lifelong dedication to expanding knowledge in medical microbiology and infectious diseases.

Professional Experience

Leonardo Mayorga has built a distinguished professional career balancing clinical practice, teaching, and leadership roles. He operates a private diagnostic and research unit in Guadalajara, focusing on medical microbiology and infectious diseases. As an academic, he serves as a professor in several prestigious institutions, including the University of Milan and the Hospital General de Hermosillo, contributing to international and national training programs. Notably, he founded the dermatological mycology diploma program at the Colegio Ibero Latinoamericano de Dermatología (CILAD), demonstrating his commitment to education and specialization development. In addition, he holds leadership positions such as Director of International Relations for the Worldwide Dermatology Collaboration Society and Secretary of the Mexican Association of Medical Mycology, reflecting his influence within the scientific community.

Research Interest

Leonardo Mayorga’s primary research interests lie in the fields of medical mycology and mycobacteriology, focusing on the diagnosis, pathogenesis, and treatment of fungal and mycobacterial infections. He is particularly invested in advancing knowledge related to dermatological fungal diseases, a niche area critical for both clinical treatment and public health. His work aims to improve diagnostic methods and therapeutic strategies, bridging laboratory research with clinical applications. Additionally, he is involved in studying tropical infectious diseases, contributing to understanding their epidemiology and management. By combining clinical expertise with academic research, Leonardo’s efforts help enhance diagnostic accuracy, patient outcomes, and education in infectious diseases, fostering progress in both local and international healthcare environments.

Award and Honor

While specific awards and honors for Leonardo Mayorga are not detailed, his professional roles and appointments indicate significant recognition in his field. Serving as Secretary of the Mexican Association of Medical Mycology for the 2024-2026 term highlights his respected leadership among peers. His position on the editorial board of the Worldwide Dermatology Journal further reflects his standing in the scientific community as an expert and influencer. Being appointed Director of International Relations for the Worldwide Dermatology Collaboration Society underscores international trust in his ability to foster collaboration and advance the field globally. These roles collectively serve as professional honors that validate his expertise, dedication, and contributions to medical microbiology and dermatology.

Conclusion

Leonardo Mayorga exemplifies a dedicated scientist and educator with a specialized focus on medical mycology and infectious diseases. His solid academic background, combined with extensive clinical practice and international teaching experience, positions him as a leader in his field. He actively advances research, education, and professional collaboration through founding academic programs and holding key leadership roles. Though explicit awards are not noted, his appointments and editorial responsibilities reflect high peer recognition and influence. Leonardo’s career is marked by a commitment to improving infectious disease diagnosis and treatment, fostering international collaboration, and shaping the future generation of specialists. His blend of scientific rigor, educational innovation, and professional service makes him a prominent figure in medical microbiology and dermatological research worldwide.

Publications Top Notes

  • Title: Vasculonecrotic Reaction in an HIV/Leprosy Coinfected Subject Caused by Mycobacterium lepromatosis

    • Authors: Fernando Amador-Lara, Jorge Leonardo Mayorga-Garibaldi, Felipe Jesus Bustos-Rodríguez, Luz Gonzalez-Hernandez, Pedro Martínez-Ayala, Jaime Federico Andrade-Villanueva

    • Year: 2025

  • Title: Global Partnerships in Dermatology

    • Author: Leonardo Mayorga

    • Year: 2025

  • Title: Disseminated Sporotrichosis in A Patient with Iatrogenic Immunosuppression Due to Suspected Pyoderma Gangrenosum

    • Author: Leonardo Mayorga

    • Year: 2024

  • Title: Mycobacterium leprae Infection in a Wild Nine-Banded Armadillo, Nuevo León, Mexico

    • Authors: Vera-Cabrera L, Ramos-Cavazos CJ, Nathan A. Youssef, Camron Pearce, Carmen Molina-Torres, Ramiro Avalos-Ramirez, Sebastien Gagneux, Ocampo-Candiani J, Gonzalez-Juarrero M, Mayorga-Rodriguez JA, et al.

    • Year: 2022

  • Title: Esporotricosis en animales domésticos

    • Author: Leonardo Mayorga

    • Year: 2021 (Book chapter)

  • Title: Tiña hiperqueratósica causada por Nannizzia gypsea: manifestación atípica en un paciente con VIH

    • Author: Leonardo Mayorga

    • Year: 2021

  • Title: Esporotricosis serie de 1,134 casos en una zona endémica de México

    • Author: Leonardo Mayorga

    • Year: 2019

  • Title: Inflammatory Tinea Manuum due to Trichophyton erinacei from an African Hedgehog

    • Author: Leonardo Mayorga

    • Year: 2018

Ayşe Özaydın | Medicine and Dentistry | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Prof. Ayşe Özaydın | Medicine and Dentistry | Best Researcher Award

Prof. Dr. (MD, MPH, PhD) at MarmaraÜniversitesi, Turkey

Prof. Dr. Ayşe Nilüfer (Gülersoy) Özaydın is a distinguished academic and public health expert with a career spanning over four decades. Born in Eskişehir, Turkey in 1959, she has contributed extensively to the fields of epidemiology, cancer prevention, reproductive health, and health education. She currently serves as a Professor in the Department of Public Health at Marmara University School of Medicine, Istanbul. Her vast experience includes roles as a guest lecturer at several medical schools, both in Turkey and Cyprus, and she has held key leadership positions in national health organizations and academic committees. Prof. Özaydın is a recognized figure in public health circles for her advocacy and pioneering work in breast cancer awareness and prevention. With numerous national and international affiliations, including WHO and GFMER, she has established herself as a thought leader and changemaker. Her work bridges clinical research, health policy, and education, impacting both public health systems and academic communities.

Professional Profile

Education

Prof. Dr. Özaydın’s academic journey began with a medical degree from Hacettepe University in 1984, followed by a master’s and Ph.D. in Public Health at the same institution. She further enhanced her expertise with postgraduate studies in Epidemiology and Statistics at the Liverpool School of Tropical Medicine in the UK. Over the years, she pursued a wide array of certifications in areas such as health education, reproductive health, clinical research methods, occupational health, and medical education, reflecting her commitment to lifelong learning and multidisciplinary expertise. She has completed advanced training courses at globally recognized institutions including Johns Hopkins University and the University of Maastricht. Her education is not only marked by academic degrees but by continuous professional development, particularly in emerging areas like cancer bioinformatics and qualitative research methods. This robust educational foundation has been critical in shaping her holistic and proactive approach to public health challenges in both academic and policy-making settings.

Professional Experience

Prof. Dr. Özaydın has accumulated extensive professional experience across clinical, academic, and governmental health sectors since beginning her career in 1984. She has worked as a physician in various public health centers across Turkey, assuming critical roles in immunization campaigns and women’s health services. Transitioning into academia, she joined Marmara University’s School of Medicine, where she advanced from lecturer to full professor in the Department of Public Health. Alongside her academic roles, she has served as a guest faculty member at institutions like Eastern Mediterranean University, Near East University, and Okan University. Her leadership includes appointments to advisory boards of the Turkish Ministry of Health, WHO initiatives, and national health strategy groups. In addition, she has held presidencies at key organizations such as the Breast Health Society (MEMEDER) and the Marmara Health Education and Research Foundation (MARSEV). Her professional record reflects deep engagement in both health system strengthening and medical education innovation.

Research Interest

Prof. Özaydın’s research interests are rooted in public health and focus extensively on breast cancer prevention, screening practices, and public awareness strategies. She is also deeply engaged in studies surrounding sexual and reproductive health, family planning, sexually transmitted infections, immunization programs, and occupational diseases. Her interdisciplinary approach merges clinical epidemiology with health education and behavior change communication. She has led and contributed to prevalence surveys, curriculum development projects, and national screening programs. Recently, she has explored newer research avenues like cancer bioinformatics and health-related social determinants in medical students. Her work is characterized by its direct impact on public health policy and community health improvement, with a particular emphasis on underserved populations. Prof. Özaydın’s research not only informs academic literature but also translates into practical guidelines and strategic plans for health ministries and global health bodies. Her studies are frequently published in peer-reviewed journals and presented at major international conferences.

Awards and Honors

Throughout her illustrious career, Prof. Özaydın has received numerous honors and appointments recognizing her academic and professional contributions. She is a valued member of the WHO Global Breast Cancer Initiative and has been invited to serve on scientific and advisory boards for Turkey’s Ministry of Health, including strategic task forces on cancer epidemiology and reproductive health. She was appointed president of MEMEDER and MARSEV, reflecting her leadership in health advocacy and education. Her contributions have been instrumental in developing national strategies for HIV/AIDS, family planning, and cancer screening. She has represented Turkey in multiple international collaborations and training programs, and her coordination role for the Geneva Foundation for Medical Education and Research highlights her global influence. Though specific award titles are not listed, her numerous appointments, leadership roles, and committee memberships across prestigious health and academic institutions serve as strong testaments to her recognition and esteem in the medical and scientific community.

Conclusion

Dr. Özaydın is a highly accomplished researcher with a distinguished career in public health, medical education, and epidemiology. Her expertise in areas like breast cancer prevention and reproductive health, along with her international collaborations and publications, positions her as a strong candidate for the Best Researcher Award. With a focus on expanding her interdisciplinary efforts and enhancing the global reach of her research, Dr. Özaydın’s contributions could be even more impactful in the future.

Publications Top Notes

  • Prevalence and risk factors of Helicobacter pylori in Turkey
    ➤ Authors: N. Özaydın, S.A. Turkyilmaz, S. Cali
    ➤ Citations: 264

  • Erkeklerde Cinsel Mitlere İnanma Oranları ve Mitlere İnanmayı Etkileyen Faktörler
    ➤Authors: F. Torun, S.D. Torun, A.N. Özaydın
    ➤ Citations: 127

  • Effect of extremely low frequency electromagnetic fields on growth rate and morphology of bacteria
    ➤ Authors: A. Inhan-Garip, B. Aksu, Z. Akan, D. Akakin, A.N. Özaydın, T. San
    ➤ Citations: 120

  • Assessment of sociodemographic and economic factors affecting immunization services in Istanbul
    ➤ Authors: H.H. Topuzoglu, A. Özaydın, G.A. Cali, D. Cebeci, S. Kalaca
    ➤ Citations: 102

  • Bahçeşehir’de oturan kadınların meme kanseri bilgi düzeyleri ve uygulamaları
    ➤ Authors: A.N. Özaydın, B.M. Güllüoğlu, P.C. Ünalan, S. Gorpe, B.R. Öner, et al.
    ➤ Citations: 71

  • Survey on a mammographic screening program in Istanbul
    ➤ Authors: V. Özmen, A.N. Özaydın, N. Cabioglu, B.M. Gulluoglu, P.C. Unalan, et al.
    ➤ Citations: 59

  • Türkiye’de evli erkeklerin aile planlaması yöntemlerini kullanmalarını etkileyen faktörler
    ➤Authors: L. Akın, N. Özaydın, D. Aslan
    ➤ Citations: 57

  • Sources of breast cancer knowledge and screening attendance – Moda, Istanbul
    ➤ Authors: A. Yildirim, A. Özaydın
    ➤ Citations: 50

  • Isotretinoin has no negative effect on attention, executive function and mood
    ➤ Authors: T. Ergun, D. Seckin, N. Özaydın, Ö. Bakar, A. Comert, et al.
    ➤ Citations: 47

  • Meme Kanserinde Tarama ve Tanı (İstanbul Konsensus Konferansı)
    ➤ Authors: S. Baskan, K. Atahan, E. Arıbal, N. Özaydın, P. Balcı, E. Yavuz
    ➤ Citations: 44

  • Cost-effectiveness of breast cancer screening in Turkey
    ➤ Authors: V. Özmen, S.Ö. Gürdal, N. Cabioğlu, B. Özcinar, A.N. Özaydın, et al.
    ➤ Citations: 38

  • Successful first round results of a Turkish breast cancer screening program
    ➤ Authors: A. Kayhan, S.Ö. Gürdal, N. Özaydın, N. Cabioglu, E. Ozturk, et al.
    ➤ Citations: 34

  • Diagnostic performance of AI for cancers in a mammography screening program
    ➤ Authors: I. Kizildag Yirgin, Y.O. Koyluoglu, M.E. Seker, S. Ozkan Gurdal, A.N. Özaydın, et al.
    ➤ Citations: 26

  • Dijital yerlilerin gözünden dijital okuryazarlık
    ➤ Authors: A. Özaydın, O. Kumral
    ➤ Citations: 23

  • The relationship between males’ attitudes to partner violence and contraception
    ➤ Authors: L. Akin, N. Özaydın
    ➤ Citations: 23

  • Kadın ve şiddet
    ➤ Authors: N. Özaydın, O. Üner, A. Akın
    ➤ Citations: 23

  • Bahçeşehir Meme Kanseri Tarama Projesi İlk Dönem Sonuçları
    ➤ Authors: A. Kayhan, S.Ö. Gürdal, N. Özaydın, E. Öztürk, N. Cabıoğlu, E. Arıbal
    ➤ Citations: 20

  • Care burden among informal caregivers of ALS patients
    ➤ Authors: Z. Tülek, A. Özakgül, N. Alankaya, A. Dik, A. Kaya, P.C. Ünalan, A.N. Özaydın, et al.
    ➤ Citations: 16

  • İstanbul/Moda’da kadınların meme kanseri bilgisi ve tarama katılımı
    ➤ Authors: A. Demir Yıldırım, A. Nilüfer Özaydın
    ➤ Citations: 16

  • İstenmeyen gebelikler ve düşüklerin kadın sağlığına etkileri
    ➤ Authors:  N. Özaydın, A. Akın
    ➤ Citations: 15